Zobrazeno 1 - 8
of 8
pro vyhledávání: '"Maoxia Zheng"'
Autor:
Marianne Uguen, Magalie Hilton, Mufiza Farid-Kapadia, Asim Datye, Saibah Chohan, Claudia Carlucci, Mark Dixon, Markus Elze, Yingjia Chen, Kit Wun Kathy Cheung, Rucha Sane, Maoxia Zheng, YounJeong Choi
Publikováno v:
Journal of Biopharmaceutical Statistics. :1-12
Autor:
Sandhya Girish, Lukas C. Amler, Howard A. Burris, Richard Alan Michaelson, Hope S. Rugo, Steven A. Limentani, Ian E. Krop, Elizabeth Tan-Chiu, Rachel A. Borson, Svetislava J. Vukelja, Maoxia Zheng, Charles L. Vogel, Barbara Klencke, Joyce O'Shaughnessy, Yu Waye Chu
Publikováno v:
Journal of Clinical Oncology. 29:398-405
Purpose The antibody-drug conjugate trastuzumab-DM1 (T-DM1) combines the biologic activity of trastuzumab with targeted delivery of a potent antimicrotubule agent, DM1, to human epidermal growth factor receptor 2 (HER2) –overexpressing cancer cells
Autor:
Maoxia Zheng, Mary Sara McPeek
Publikováno v:
The American Journal of Human Genetics. 80:112-125
The HapMap Project is providing a great deal of new information on high-resolution haplotype structure in various human populations. This information has the potential to greatly increase the power of association mapping for a fixed amount of genotyp
Autor:
Tom Mikkelsen, W. K. Alfred Yung, Maoxia Zheng, David Schiff, Michael D. Prados, Randy L. Jensen, Henry S. Friedman, Martin K. Nicholas, Timothy F. Cloughesy, Nina Paleologos, Patrick Y. Wen, Lauren E. Abrey, James J. Vredenburgh, Jane Huang
Publikováno v:
Journal of Clinical Oncology. 28:e190-e192
Autor:
Maoxia Zheng, David Schiff, James J. Vredenburgh, W. K. Alfred Yung, Randy L. Jensen, Jane Huang, Michael D. Prados, Timothy F. Cloughesy, Nina Paleologos, Henry S. Friedman, Tom Mikkelsen, Lauren E. Abrey, Martin K. Nicholas, Patrick Y. Wen
Publikováno v:
Journal of clinical oncology : official journal of the American Society of Clinical Oncology. 27(28)
Purpose We evaluated the efficacy of bevacizumab, alone and in combination with irinotecan, in patients with recurrent glioblastoma in a phase II, multicenter, open-label, noncomparative trial. Patients and Methods One hundred sixty-seven patients we
Autor:
Maoxia Zheng, Mary Sara McPeek
Publikováno v:
Computational Methods for SNPs and Haplotype Inference ISBN: 9783540212492
Computational Methods for SNPs and Haplotype Inference
Computational Methods for SNPs and Haplotype Inference
Our ultimate interest is in formalization of models for high-resolution haplotype structure in such a way that they can be useful in statistical methods for linkage disequilibrium (LD) mapping. Some steps in that direction have been taken by Daly et
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::64e2633b8939d0687a3f8e1470d3ce18
https://doi.org/10.1007/978-3-540-24719-7_9
https://doi.org/10.1007/978-3-540-24719-7_9
Autor:
Svetislava J. Vukelja, Yu-Waye Chu, Ian E. Krop, Lukas C. Amler, Maoxia Zheng, Hope S. Rugo, H. A. Burris, Kathy D. Miller, Patricia LoRusso, M. Lu
Publikováno v:
Journal of Clinical Oncology. 28:1016-1016
1016 Background: The antibody-drug conjugate T-DM1 has shown encouraging efficacy in two phase II studies (4258g and 4374g) for pts with HER2-positive (HER2+) MBC who had progressed on prior HER2-d...
Autor:
Samuel Agresta, Kathy D. Miller, Lukas C. Amler, Gladys Rodriguez, Denise A. Yardley, Patricia LoRusso, Ian E. Krop, Maoxia Zheng, Hope S. Rugo, Shanu Modi
Publikováno v:
Cancer Research. 69:5090-5090
ABSTRACT WITHDRAWN: This abstract was withdrawn by the authors prior to the start of the Symposium. It was rescheduled to a Poster Discussion session and renumbered as Abstract 710. Background: T-DM1 combines the HER2-inhibiting properties of trastuz